Skip to content

Clinical trials

Purpura, Thrombocytopenic, Idiopathic trials in Greece

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Purpura, Thrombocytopenic, Idiopathic Country / region: Greece Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20062
20131
20141
20181
20191
20203
20211
20254

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting3
Active, not recruiting1
Not yet recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
Takeda3
GlaxoSmithKline2
argenx2
Amgen1
Climb Bio, Inc.1
Hellenic Society of Hematology1
Oscotec Inc.1
UCB Biopharma SRL1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Purpura, Thrombocytopenic, Idiopathic15
Purpura5
Thrombocytopenia4
Hemorrhage3
Autoimmune Diseases2
Blood Platelet Disorders2
Cytopenia2
Hematologic Diseases2
Hemorrhagic Disorders2
Immune System Diseases2

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.